Browse Studies — Arctuva

The Deucravacitinib Pregnancy Exposure Study: A Prospective Observational Study of Deucravacitinib Safety in Pregnancy

The purpose of this study is to assess pregnancy and infant outcomes among pregnant participants enrolled in an established North American pregnancy registry (…

Psoriasis (PsO)

Estimated

~$10 – $1,125

Bristol-Myers SquibbNCT07017699

Phase 4

A Randomized, Double-blind, Placebo-controlled Crossover Trial of Antiplatelet Therapies in Psoriasis

The purpose of this study is to determine the effect of antiplatelet therapy on the endovascular phenotype in psoriasis, specifically whether clopidogrel reduc…

Psoriasis (PsO)Psoriatic Arthritis (PsA)

Estimated

~$10 – $7,500

NYU Langone HealthNCT07744191

Observational

The Effects of Audio-Based Therapy on Anxiety in Psoriasis

Anxiety in psoriasis is associated with impaired quality of life, and the prevalence of anxiety symptoms in psoriatic populations is approximately 34% and anxi…

Psoriasis (PsO)Anxiety

Estimated

~$10 – $5,625

University of California, San FranciscoNCT07390487

Phase 1

Phase 1b Randomized, Double Blind, Placebo-controlled Study to Evaluate Safety, Tolerability and Pharmacokinetics of LPX-TI641 in Patients With Atopic Dermatitis and Psoriasis

The goal of this clinical trial is to study the drug LPX-TI641 in patients with atopic dermatitis and psoriasis. We will compare the safety and tolerability of…

Atopic Dermatitis (AD)Psoriasis (PsO)

Estimated

~$10 – $8,750

LAPIX Therapeutics Inc.NCT06982352